219 related articles for article (PubMed ID: 38159118)
21. Crystal structure of murine cyclophilin C complexed with immunosuppressive drug cyclosporin A.
Ke H; Zhao Y; Luo F; Weissman I; Friedman J
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11850-4. PubMed ID: 8265636
[TBL] [Abstract][Full Text] [Related]
22. The adhesion protein of Mycoplasma genitalium inhibits urethral epithelial cell apoptosis through CypA-CD147 activating PI3K/ Akt/NF-κB pathway.
Liao Y; Peng K; Li X; Ye Y; Liu P; Zeng Y
Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6657-6669. PubMed ID: 36066653
[TBL] [Abstract][Full Text] [Related]
23. Extracellular and Intracellular Cyclophilin A, Native and Post-Translationally Modified, Show Diverse and Specific Pathological Roles in Diseases.
Xue C; Sowden MP; Berk BC
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):986-993. PubMed ID: 29599134
[TBL] [Abstract][Full Text] [Related]
24. X-ray structure of a cyclophilin B/cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain.
Mikol V; Kallen J; Walkinshaw MD
Proc Natl Acad Sci U S A; 1994 May; 91(11):5183-6. PubMed ID: 8197205
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity.
Hong F; Lee J; Song JW; Lee SJ; Ahn H; Cho JJ; Ha J; Kim SS
FASEB J; 2002 Oct; 16(12):1633-5. PubMed ID: 12207006
[TBL] [Abstract][Full Text] [Related]
26. Cyclophilin A inhibition as potential treatment of human aortic valve calcification.
Perrucci GL; Songia P; Moschetta D; Barbagallo VA; Valerio V; Myasoedova VA; Alfieri V; Massaiu I; Roberto M; Malešević M; Pompilio G; Poggio P
Pharmacol Res; 2020 Aug; 158():104888. PubMed ID: 32434054
[TBL] [Abstract][Full Text] [Related]
27. Cyclophilin A in cardiovascular homeostasis and diseases.
Satoh K
Tohoku J Exp Med; 2015 Jan; 235(1):1-15. PubMed ID: 25743766
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.
Han W; Soltani K; Ming M; He YY
Cancer Prev Res (Phila); 2012 Sep; 5(9):1155-62. PubMed ID: 22846842
[TBL] [Abstract][Full Text] [Related]
29. Structural and biochemical insights of CypA and AIF interaction.
Farina B; Di Sorbo G; Chambery A; Caporale A; Leoni G; Russo R; Mascanzoni F; Raimondo D; Fattorusso R; Ruvo M; Doti N
Sci Rep; 2017 Apr; 7(1):1138. PubMed ID: 28442737
[TBL] [Abstract][Full Text] [Related]
30. Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles.
Castro AP; Carvalho TM; Moussatché N; Damaso CR
J Virol; 2003 Aug; 77(16):9052-68. PubMed ID: 12885921
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.
Xue C; Sowden M; Berk BC
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1138-1146. PubMed ID: 28450293
[TBL] [Abstract][Full Text] [Related]
32. Cyclophilin A: a key player for human disease.
Nigro P; Pompilio G; Capogrossi MC
Cell Death Dis; 2013 Oct; 4(10):e888. PubMed ID: 24176846
[TBL] [Abstract][Full Text] [Related]
33. Cyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy.
Dawar FU; Tu J; Khattak MN; Mei J; Lin L
Curr Issues Mol Biol; 2017; 21():1-20. PubMed ID: 27033630
[TBL] [Abstract][Full Text] [Related]
34. Natural Cyclophilin A Inhibitors Suppress the Growth of Cancer Stem Cells in Non-Small Cell Lung Cancer by Disrupting Crosstalk between CypA/CD147 and EGFR.
Han JM; Kim SM; Kim HL; Cho HJ; Jung HJ
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298389
[TBL] [Abstract][Full Text] [Related]
35. Cyclophilin A is a mitochondrial factor that forms complexes with p23 - correlative evidence for an anti-apoptotic action.
Daneri-Becerra C; Valeiras B; Gallo LI; Lagadari M; Galigniana MD
J Cell Sci; 2021 Feb; 134(3):. PubMed ID: 33361281
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress.
Doti N; Reuther C; Scognamiglio PL; Dolga AM; Plesnila N; Ruvo M; Culmsee C
Cell Death Dis; 2014 Jan; 5(1):e993. PubMed ID: 24434516
[TBL] [Abstract][Full Text] [Related]
37. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 37 (IL-37) Reduces High Glucose-Induced Inflammation, Oxidative Stress, and Apoptosis of Podocytes by Inhibiting the STAT3-Cyclophilin A (CypA) Signaling Pathway.
Zhang X; Zhu Y; Zhou Y; Fei B
Med Sci Monit; 2020 Sep; 26():e922979. PubMed ID: 32931486
[TBL] [Abstract][Full Text] [Related]
39. Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.
Lee J
Arch Pharm Res; 2010 Sep; 33(9):1401-9. PubMed ID: 20945139
[TBL] [Abstract][Full Text] [Related]
40. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
